Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem, 48689-48690 [2024-12567]
Download as PDF
<![CDATA[
48689
Federal Register / Vol. 89, No. 111 / Friday, June 7, 2024 / Notices
Procedures, Electronic Filing
Procedures 1).
Please note the Secretary’s Office will
accept only electronic filings during this
time. Filings must be made through the
Commission’s Electronic Document
Information System (EDIS, https://
edis.usitc.gov.) No in-person paperbased filings or paper copies of any
electronic filings will be accepted until
further notice. Persons with questions
regarding filing should contact the
Secretary at EDIS3Help@usitc.gov.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) by the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. appendix 3; or (ii) by U.S.
Government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
By order of the Commission.
Issued: June 4, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024–12538 Filed 6–6–24; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1382]
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chem
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 6, 2024. Such
persons may also file a written request
for a hearing on the application on or
before August 6, 2024.
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 8, 2024, American
Radiolabeled Chem, 101 Arc Drive,
Saint Louis, Missouri 63146–3502,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
American Radiolabeled Chem
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...............................................................................................................................................
Ibogaine ...............................................................................................................................................................................
Lysergic acid diethylamide ..................................................................................................................................................
Tetrahydrocannabinols ........................................................................................................................................................
Dimethyltryptamine ..............................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...................................................................................................................................
Noroxymorphone .................................................................................................................................................................
Heroin ..................................................................................................................................................................................
Normorphine ........................................................................................................................................................................
Amphetamine .......................................................................................................................................................................
Methamphetamine ...............................................................................................................................................................
Amobarbital ..........................................................................................................................................................................
Phencyclidine .......................................................................................................................................................................
Phenylacetone .....................................................................................................................................................................
Cocaine ................................................................................................................................................................................
Codeine ...............................................................................................................................................................................
Dihydrocodeine ....................................................................................................................................................................
Oxycodone ...........................................................................................................................................................................
Hydromorphone ...................................................................................................................................................................
Ecgonine ..............................................................................................................................................................................
Hydrocodone .......................................................................................................................................................................
Meperidine ...........................................................................................................................................................................
Metazocine ..........................................................................................................................................................................
Methadone ...........................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..................................................................................................................
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
VerDate Sep<11>2014
17:23 Jun 06, 2024
Jkt 262001
2 All contract personnel will sign appropriate
nondisclosure agreements.
PO 00000
Frm 00140
Fmt 4703
Sfmt 4703
2010
7260
7315
7370
7435
7470
9145
9200
9313
1100
1105
2125
7471
8501
9041
9050
9120
9143
9150
9180
9193
9230
9240
9250
9273
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
E:\FR\FM\07JNN1.SGM
07JNN1
48690
Federal Register / Vol. 89, No. 111 / Friday, June 7, 2024 / Notices
Controlled substance
Drug code
Morphine ..............................................................................................................................................................................
Oripavine .............................................................................................................................................................................
Thebaine ..............................................................................................................................................................................
Oxymorphone ......................................................................................................................................................................
Phenazocine ........................................................................................................................................................................
Carfentanil ...........................................................................................................................................................................
Fentanyl ...............................................................................................................................................................................
Drug Enforcement Administration
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
[Docket No. DEA–1383]
SUPPLEMENTARY INFORMATION:
The company plans to bulk
manufacture the listed controlled
substances for internal use as
intermediates or for sale to its
customers. The company plans to
manufacture small quantities of the
above listed controlled substances as
radiolabeled compounds for
biochemical research. In reference to
drug code 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–12567 Filed 6–6–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Application: Usona Institute
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Usona Institute has applied to
be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 8, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 8, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
ddrumheller on DSK120RN23PROD with NOTICES1
DATES:
VerDate Sep<11>2014
18:54 Jun 06, 2024
Jkt 262001
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 13, 2024, Usona
Institute, 2780 Woods Hollow Road,
Room 2412, Fitchburg, Wisconsin
53711–5370, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
Controlled substance
5-Methoxy-N-Ndimethyltryptamine.
Dimethyltryptamine ..........
Psilocybin ........................
Psilocyn ...........................
Drug
code
Schedule
7431
I
7435
7437
7438
I
I
I
The company plans to import the
listed controlled substances for research
and analytical purposes. The materials
will not be used for clinical trials or
human consumption. No other activities
for these drug codes are authorized for
this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
PO 00000
Frm 00141
Fmt 4703
Sfmt 4703
9300
9330
9333
9652
9715
9743
9801
Schedule
II
II
II
II
II
II
II
approved finished dosage forms for
commercial sale.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2024–12575 Filed 6–6–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1384]
Bulk Manufacturer of Controlled
Substances Application: Veranova,
L.P.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Veranova, L.P., has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 6, 2024. Such
persons may also file a written request
for a hearing on the application on or
before August 6, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUMMARY:
E:\FR\FM\07JNN1.SGM
07JNN1
]]>Agencies
[Federal Register Volume 89, Number 111 (Friday, June 7, 2024)]
[Notices]
[Pages 48689-48690]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-12567]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1382]
Bulk Manufacturer of Controlled Substances Application: American
Radiolabeled Chem
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: American Radiolabeled Chem has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
August 6, 2024. Such persons may also file a written request for a
hearing on the application on or before August 6, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 8, 2024, American Radiolabeled Chem, 101 Arc
Drive, Saint Louis, Missouri 63146-3502, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............ 2010 I
Ibogaine............................. 7260 I
Lysergic acid diethylamide........... 7315 I
Tetrahydrocannabinols................ 7370 I
Dimethyltryptamine................... 7435 I
1-[1-(2-Thienyl)cyclohexyl]piperidine 7470 I
Noroxymorphone....................... 9145 I
Heroin............................... 9200 I
Normorphine.......................... 9313 I
Amphetamine.......................... 1100 II
Methamphetamine...................... 1105 II
Amobarbital.......................... 2125 II
Phencyclidine........................ 7471 II
Phenylacetone........................ 8501 II
Cocaine.............................. 9041 II
Codeine.............................. 9050 II
Dihydrocodeine....................... 9120 II
Oxycodone............................ 9143 II
Hydromorphone........................ 9150 II
Ecgonine............................. 9180 II
Hydrocodone.......................... 9193 II
Meperidine........................... 9230 II
Metazocine........................... 9240 II
Methadone............................ 9250 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
[[Page 48690]]
Morphine............................. 9300 II
Oripavine............................ 9330 II
Thebaine............................. 9333 II
Oxymorphone.......................... 9652 II
Phenazocine.......................... 9715 II
Carfentanil.......................... 9743 II
Fentanyl............................. 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for internal use as intermediates or for sale to its
customers. The company plans to manufacture small quantities of the
above listed controlled substances as radiolabeled compounds for
biochemical research. In reference to drug code 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetic. No other activities for these drug codes are
authorized for this registration.
Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-12567 Filed 6-6-24; 8:45 am]
BILLING CODE 4410-09-P
